Glaucocalyxin A delays the progression of OA by inhibiting NF-κB and MAPK signaling pathways
Abstract Background Osteoarthritis (OA) is a common degenerative joint condition marked by inflammation and cartilage breakdown. Currently, there is a dearth of treatment medications that can clearly slow the course of OA. Glaucocalyxin A (GLA) is a diterpene chemical identified and extracted from R...
Salvato in:
| Autori principali: | , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMC
2024-03-01
|
| Serie: | Journal of Orthopaedic Surgery and Research |
| Soggetti: | |
| Accesso online: | https://doi.org/10.1186/s13018-024-04640-z |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|